Amgen Inc
NASDAQ:AMGN
Amgen Inc
Other Items
Amgen Inc
Other Items Peer Comparison
Competitive Other Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amgen Inc
NASDAQ:AMGN
|
Other Items
-$26.8B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Abbvie Inc
NYSE:ABBV
|
Other Items
-$10.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-28%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Items
-$3.1B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Moderna Inc
NASDAQ:MRNA
|
Other Items
$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
77%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Items
-$3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-79%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Items
-$3.8B
|
CAGR 3-Years
-212%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-32%
|
See Also
What is Amgen Inc's Other Items?
Other Items
-26.8B
USD
Based on the financial report for Mar 31, 2024, Amgen Inc's Other Items amounts to -26.8B USD.
What is Amgen Inc's Other Items growth rate?
Other Items CAGR 10Y
-10%
Over the last year, the Other Items growth was -668%. The average annual Other Items growth rates for Amgen Inc have been -77% over the past three years , and -10% over the past ten years .